The aim of this study was to explore EGFR, CD44v6 and BRAF as molecular targets in thyroid cancer by assessing patient samples from PFC, FTC and ATC, as well as in cultured thyroid cancer cell lines. This evidence concerns the gene BRAF and thyroid cancer.